Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific to Distribute Response Bio's Ramp Cardiac Product in Canada

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fisher Scientific will exclusively distribute Response Biomedical's RAMP cardiac products in Canada under a deal announced today.

Financial and other terms of the agreement were not disclosed.

Fisher Scientific is part of Thermo Fisher Scientific.

According to Vancouver, British Columbia-based Response Biomedical, point-of-care testing in Canada is projected to reach C$63 million ($66.2 million) this year with an estimated growth rate of 7 percent over the next few years.

Response Bio's RAMP system consists of a reader and single-use disposable test cartridges. RAMP clinical tests are commercially available for the early detection of heart attack and congestive heart failure.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.